DK0452598T3 - Anvendelsen af et polypeptid med humant-inter-leukin-2-aktivitet til fremstilling af farmaceutiske præparater til behandling af primitiv pleuracancer - Google Patents

Anvendelsen af et polypeptid med humant-inter-leukin-2-aktivitet til fremstilling af farmaceutiske præparater til behandling af primitiv pleuracancer

Info

Publication number
DK0452598T3
DK0452598T3 DK90401533.6T DK90401533T DK0452598T3 DK 0452598 T3 DK0452598 T3 DK 0452598T3 DK 90401533 T DK90401533 T DK 90401533T DK 0452598 T3 DK0452598 T3 DK 0452598T3
Authority
DK
Denmark
Prior art keywords
polypeptide
activity
primitive
preparation
human interleukin
Prior art date
Application number
DK90401533.6T
Other languages
Danish (da)
English (en)
Inventor
Danielle Lando
Maud Brandely
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of DK0452598T3 publication Critical patent/DK0452598T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK90401533.6T 1990-04-17 1990-06-06 Anvendelsen af et polypeptid med humant-inter-leukin-2-aktivitet til fremstilling af farmaceutiske præparater til behandling af primitiv pleuracancer DK0452598T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9004895A FR2660863B1 (fr) 1990-04-17 1990-04-17 Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour preparer une composition pharmaceutique destinee au traitement de cancers primitifs de la plevre.

Publications (1)

Publication Number Publication Date
DK0452598T3 true DK0452598T3 (da) 1994-01-17

Family

ID=9395818

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90401533.6T DK0452598T3 (da) 1990-04-17 1990-06-06 Anvendelsen af et polypeptid med humant-inter-leukin-2-aktivitet til fremstilling af farmaceutiske præparater til behandling af primitiv pleuracancer

Country Status (13)

Country Link
US (1) US5219565A (ja)
EP (1) EP0452598B1 (ja)
JP (1) JP2848922B2 (ja)
KR (1) KR0165674B1 (ja)
AT (1) ATE97575T1 (ja)
AU (1) AU631649B2 (ja)
CA (1) CA2018630A1 (ja)
DE (1) DE69004794T2 (ja)
DK (1) DK0452598T3 (ja)
FR (1) FR2660863B1 (ja)
HU (1) HU205261B (ja)
OA (1) OA09213A (ja)
ZA (1) ZA904353B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2668368B1 (fr) * 1990-10-30 1995-03-10 Roussel Uclaf Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour preparer une composition pharmaceutique destinee au traitement des tumeurs malignes epitheliales.
FR2671728B1 (fr) * 1991-01-17 1995-01-20 Roussel Uclaf Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour la preparation de compositions pharmaceutiques destinees au traitement des pneumathorax.
FR2684878B1 (fr) * 1991-12-12 1994-02-11 Roussel Uclaf Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation.
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5419900A (en) 1993-05-19 1995-05-30 The United States Of America As Represented By The Department Of Of Health And Human Services Immunologic enhancement with intermittent interleukin-2 therapy
US5696079A (en) * 1993-05-19 1997-12-09 The United States Of America As Represented By The Department Of Health And Human Services Immunologic enhancement with intermittent interleukin-2 therapy
EP1274720A4 (en) * 2000-04-12 2004-08-18 Human Genome Sciences Inc FUSION PROTEINS CONTAINING ALBUMIN
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
WO2002097038A2 (en) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Chemokine beta-1 fusion proteins
PT1463751E (pt) 2001-12-21 2013-08-26 Human Genome Sciences Inc Proteínas de fusão de albumina
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
WO2023070000A1 (en) * 2021-10-20 2023-04-27 William Marsh Rice University Methods of use and administration of encapsulated cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0031539B1 (en) * 1979-12-28 1987-03-25 International Business Machines Corporation Voltage distribution system of an lsi chip
FR2635527B1 (fr) * 1988-07-28 1992-06-12 Roussel Uclaf Il2 humaine recombinante non glycosylee sous forme reduite, son procede d'obtention et son application comme medicament

Also Published As

Publication number Publication date
AU631649B2 (en) 1992-12-03
ZA904353B (en) 1991-08-28
JPH045241A (ja) 1992-01-09
AU5693590A (en) 1991-11-21
HU903769D0 (en) 1990-11-28
FR2660863A1 (fr) 1991-10-18
KR910018038A (ko) 1991-11-30
HU205261B (en) 1992-04-28
EP0452598B1 (fr) 1993-11-24
JP2848922B2 (ja) 1999-01-20
OA09213A (fr) 1992-06-30
ATE97575T1 (de) 1993-12-15
DE69004794D1 (de) 1994-01-05
EP0452598A1 (fr) 1991-10-23
FR2660863B1 (fr) 1994-01-21
KR0165674B1 (ko) 1999-01-15
CA2018630A1 (fr) 1991-10-17
HUT56721A (en) 1991-10-28
US5219565A (en) 1993-06-15
DE69004794T2 (de) 1994-04-14

Similar Documents

Publication Publication Date Title
DE3586833D1 (de) Synergistische mischungen von interferonen und tumor-nekrose-faktor.
AU638982B2 (en) Use of cytokines
ZA907648B (en) Use of a polypeptide having the activity of human interleukine 2 for the preparation of pharmaceutical compositions intended for the treatment of leukemias
EP0271211A3 (en) Use of cartilage-inducing factor b (cif-b) for the manufacture of a medicament for inhibiting tumor growth
ZA904353B (en) Use of a polypeptide having the activity of human interleukin 2 for preparing a pharmaceutical composition intended for the treatment of primary cancers of the pleura
EP0553294A4 (en) Methods and compositions for the treatment of cell proliferation disorders
DK0643973T3 (da) Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
NO863027L (no) Peptidpreparater med kontinuerlig avgivelse.
DE3572441D1 (en) Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases
HUT63575A (en) Stabilized pharmaceutical composition comprising the reduced form of non-glycosylated, recombinant human interleukin-2
DK0507825T3 (da) Antitumoralt præparat på basis af polypeptider med humant interleukin-2-aktivitet
IE871358L (en) Interferon for carcinoma
SE9000793L (sv) Sdk-peptider,foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem
DK0495721T3 (da) Anvendelsen af et polypeptid med en humant-interleukin-2-aktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af pneumothorax
AU645042B2 (en) Use of a polypeptide having the activity of gamma interferon for the preparation of pharmaceutical compositions intended for the treatment of primary cancers of the pleura
Macey et al. Interleukin-2 (IL-2) immunotherapy
KR900012628A (ko) 감마 인터페론의 유효량을 함유하는 복강내 투여용 난소암 치료제